Soligenix Inc (SNGX)

[smallcapguru]

jbem777, I like your work and nice write up on SNGX. Take a look at the press release on March 3, 2015 entitled: "Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients." Note the quote from SNGX CMO: "This initial dose-ranging clinical trial was specifically designed to examine 3 dose levels of SGX942 versus placebo and, if statistically justified, to continue enrollment in any patient/dose groups in which there was promise of potentially demonstrating a positive and clinically-meaningful outcome," stated Richard Straube, MD, Senior Vice President and Chief Medical Officer of Soligenix. "This positive recommendation from the DRC will allow for a sufficient number of subjects to be enrolled into the most promising dose group to increase the potential of demonstrating a positive effect with SGX942 on this catastrophic side-effect of cancer treatment that remains a significant unmet medical need."

Dr. Straube continued, "Given the additional subjects to be enrolled and our primary endpoint assessment through 11 weeks, timing to top-line results may move into the second half of this year."

Looking forward to the data release :)